Supporting the Pharmaceutical Industry with 21 CFR Part 11 Compliance Readiness
White Paper Apr 24, 2018
The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.
Integration of PANalytical systems in a 21 CFR Part 11 compliant laboratory environment was straightforward because PANalytical offers tools and services to guarantee authenticity, integrity and confidentiality of electronic records and electronic signatures. Also the final system qualification is supported with products and services.
Related White Papers
Analysis of Microplastics Using Mobile FTIR and FTIR ImagingWhite Paper
Identifying and quantifying microplastics in wastewater, sediment and fauna.READ MORE
Exploring the Hallmarks of Cancer with Real-time Live-cell AnalysisWhite Paper
The constantly evolving picture of tumor biology is helping to shed new light on the behavior of many cancers, as well as providing new pharmacological targets and treatment strategies.READ MORE